Vitiligo Associated with Melanoma in a Malagasy Woman.


Journal

Case reports in dermatological medicine
ISSN: 2090-6463
Titre abrégé: Case Rep Dermatol Med
Pays: United States
ID NLM: 101591808

Informations de publication

Date de publication:
2019
Historique:
received: 07 07 2019
revised: 18 09 2019
accepted: 01 10 2019
entrez: 13 12 2019
pubmed: 13 12 2019
medline: 13 12 2019
Statut: epublish

Résumé

Malignant melanoma is the first fatal skin cancer. Vitiligo is a leukoderma or a multifactorial depigmentation acquired but especially of autoimmune origin. We report the first Malagasy case affected by both melanoma and Vitiligo. The appearance of Vitiligo during a melanoma could testify to an immunological response against melanocytes. Despite the association of melanoma and Vitiligo, the prognosis of melanoma is still fatal.

Identifiants

pubmed: 31827944
doi: 10.1155/2019/7925785
pmc: PMC6885251
doi:

Types de publication

Case Reports

Langues

eng

Pagination

7925785

Informations de copyright

Copyright © 2019 I. M. Ranaivo et al.

Déclaration de conflit d'intérêts

All authors declare that there is no have no conflict of interests regarding the publication of this paper.

Références

JAMA Dermatol. 2016 Jan;152(1):45-51
pubmed: 26501224
Genome Med. 2010 Oct 19;2(10):78
pubmed: 20959028
J Am Acad Dermatol. 2013 Jul;69(1):e28-9
pubmed: 23768302
Int J Dermatol. 2019 Aug;58(8):908-911
pubmed: 31148154
J Invest Dermatol. 1999 Dec;113(6):1033-8
pubmed: 10594748
N Engl J Med. 2008 Jul 17;359(3):e3
pubmed: 18635425
Actas Dermosifiliogr. 2014 Mar;105(2):122-7
pubmed: 23146137
J Am Acad Dermatol. 2019 May;80(5):1215-1231.e6
pubmed: 30236516
Pigment Cell Melanoma Res. 2015 May;28(3):360-2
pubmed: 25645285
J Am Acad Dermatol. 2016 Dec;75(6):1198-1204
pubmed: 27717621
Int J Dermatol. 2005 Oct;44 Suppl 1:46-8
pubmed: 16187962
Clin Exp Dermatol. 2009 Mar;34(2):209-11
pubmed: 18691245
Lancet. 2015 Jul 4;386(9988):74-84
pubmed: 25596811

Auteurs

I M Ranaivo (IM)

Department of Dermatology, University Hospital Morafeno, Toamasina, Madagascar.

F A Sendrasoa (FA)

Department of Dermatology, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.

M Andrianarison (M)

Department of Dermatology, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.

M Razakanaivo (M)

Department of Oncology, University Hospital Joseph Ravoahangy Andrianavalona, Antananarivo, Madagascar.

L S Ramarozatovo (LS)

Department of Dermatology, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.

F Rafaramino (F)

Department of Oncology, University Hospital Joseph Ravoahangy Andrianavalona, Antananarivo, Madagascar.

F Rapelanoro Rabenja (F)

Department of Dermatology, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.

Classifications MeSH